Liver cancer
11,658 new cases in France in 2023 1
What is it?
Hepatocellular carcinoma arises from hepatocytes, the main cells of the liver. It is the main form of cancer that starts in the liver, distinct from metastases that have spread from another organ 2.
How it develops
In about 9 in 10 cases, it develops in a liver already damaged by cirrhosis. The usual sequence is chronic damage (alcohol, viral hepatitis, fatty liver), followed by fibrosis, cirrhosis and nodules that may become cancerous. The tumor then spreads within the liver and its blood vessels, and later to distant sites 2.
How long does it take to develop?
Progression from chronic damage to cirrhosis generally takes years or even decades. With cirrhosis, the risk of cancer is 1 to 5 % per year 2. Once formed, the tumor doubles in volume in about 4,6 months on average 3, which is why people at risk are monitored every 6 months.
Risk factors
- Alcohol, responsible for nearly half of new cases
- Hepatitis B (and D) and C
- Excess weight, obesity and type 2 diabetes (fatty liver)
- Tobacco
- Cirrhosis, whatever its cause
What helps protect you: Hepatitis B vaccination, treatment of viral hepatitis, limiting alcohol, managing weight and blood glucose 2.
Signs that should prompt a visit to your doctor
In the early stages
- Most often, no symptoms
- Often found during follow-up for liver disease
As it progresses
- Persistent severe fatigue
- Loss of appetite, nausea
- Pain on the right side, under the ribs
At an advanced stage
- Jaundice: yellowing of the skin and eyes
- Abdominal swelling (ascites)
- A decline in overall health
These signs do not mean you have cancer: they may have other causes. Unsure? Talk to your doctor.
⁴Early cancer often goes unnoticed. See a doctor for unexplained loss of weight or appetite, discomfort under the ribs on the right side, a swollen abdomen or jaundice. These signs most often have other causes 5.
Detected early or at a later stage
When detected early, there is a single tumor or a small number of tumors confined to the liver: surgery or local destruction is then possible. In the United States: 45 % localized, 23 % regional, 21 % distant 6.
5-year survival by stage
In France, 5-year net survival reaches about 50 % in people eligible for surgery or local destruction 2.
Approximate correspondence with the clinical classification (TNM/FIGO); this varies depending on the tumour's characteristics.
Screening in France
No national program. For people with cirrhosis: liver ultrasound and alpha-fetoprotein testing every 6 months 2.
Monitoring for people at risk
For people at risk (alcohol, excess weight, diabetes, hepatitis), their primary care doctor reassesses liver health each year 2.

Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →Frequently asked questions
Do I need a prescription?
No. With Prevonco, you do not need a prescription: after ordering online, a unique code gives you access to the test at one of our partner laboratories. In France, some laboratory tests can be carried out at your request, without a prescription.
No prescription, but still a doctor: they remain central to the process. Your result is sent to the doctor you selected from our panel, who will explain it during a 30-minute video consultation, included whatever the result.
Are you receiving care for cancer? Speak directly to your oncologist: they can prescribe this test without going through Prevonco.
For any questions about your situation, or if you have symptoms, your doctor remains your first point of contact.
What if my level is high?
A high level tends to be a strong signal. It is not a conclusion: its cause needs to be investigated with a doctor.⁷
Your result is sent to the doctor you selected from our panel. They will explain it during the 30-minute video consultation included in the price. Further investigations prescribed by a doctor can help identify the cause.⁷
What if the level is intermediate? It may not be related to cancer (smoking, an inflammatory condition, etc.). Other blood tests may be suggested; if they are normal, a repeat check is planned at 12 months. You will never be left to face your result alone.⁷
What if my level is low?
That is reassuring, but no test is perfect: a low level does not rule everything out.⁷
If you have no symptoms, no specific follow-up is recommended after a low result. The risk of a false negative varies by cancer type.⁷
Your doctor, who is trained in functional medicine and specialises in prevention, will help you explore any concerns or symptoms during the 30-minute video consultation.⁷
Keep up with your usual screening: respond to invitations for organised screening programmes, and see your doctor if a symptom appears.⁷
How long will it take to get my results?
The laboratory analysis takes 30 days. Your full results are presented by a doctor trained in functional medicine during a 30-minute consultation included in your package.
You choose the date and time slot that suit you for this appointment.
Prevonco is currently available in France only.
An aid to the early detection of 16 cancers
No prescription needed, for people without symptoms. If you have an unexplained symptom, see your doctor first.
Pre-register for free →General information for educational purposes: it does not replace your doctor's advice. An aid to early detection: it does not replace organised screening, imaging tests or your doctor's advice.
Sources
- 1.INCa, Panorama des cancers en France, 2026
- 2.INCa, cancer du foie : repérage et suivi des patients à risque en médecine générale, 2022
- 3.INCa / Gut, 2020 : temps de doublement du carcinome hépatocellulaire (méta-analyse)
- 4.INCa (cancer.fr, 2022 and 07/10/2026); Fondation ARC; Fondation A.R.CA.D
- 5.American Cancer Society, signes du cancer du foie
- 6.NCI SEER, Cancer Stat Facts – Liver and Intrahepatic Bile Duct Cancer (2016-2022)
- 7.biodena.care